ZCM
IRWD icon

Zebra Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Zebra Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,536
Closed -$274K – 147
2021
Q4 		$274K Sell
23,536
-8,676
-27% -$106K 0.44% 81
2021
Q3 		$421K Sell
32,212
-21,147
-40% -$273K 0.51% 60
2021
Q2 		$687K Sell
53,359
-5,763
-10% -$66K 0.81% 42
2021
Q1 		$661K Buy
+59,122
New +$625K 0.73% 47

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zebra Capital Management's IRWD Position: Q1 2022 in Review

Zebra Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2022, closing a stake of 23,536 shares — an estimated $274K sold.

Zebra Capital Management first reported a position in IRWD in Q1 2021 and held it in 4 quarters. The position peaked at $687K in Q2 2021. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

  • Zebra Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Zebra Capital Management sold 23,536 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $274K.
  • Zebra Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 4 quarters.
  • Zebra Capital Management's Ironwood Pharmaceuticals position peaked at $687K in Q2 2021.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Zebra Capital Management's 13F filing for Q1 2022, filed 16 May 2022.